Obesity research has increasingly moved beyond the stomach and into the brain, where specialized neural circuits help determine when an animal feels hungry, how much it eats, and how its body uses energy. A new study from Osaka Metropolitan University suggests that a mitochondrial protein inside a specific population of hypothalamic neurons may influence how strongly the brain responds to dietary fat. In experiments involving mice, the researchers found that disrupting the protein optic atrophy-1, or OPA1, increased food intake, promoted age-related weight gain, and weakened the appetite-suppressing effects of an anti-obesity drug in females. The findings offer a possible explanation for why high-fat foods can affect individuals differently and why biological sex may be an important factor in obesity treatment.
The research was led by Professor Shigenobu Matsumura of Osaka Metropolitan University’s Graduate School of Human Life and Ecology. The team focused on neurons that express melanocortin-4 receptor, commonly known as MC4R. These neurons are located in the hypothalamus, a brain region that coordinates appetite, energy expenditure, body weight, temperature, and several other physiological functions. MC4R signaling is one of the central pathways involved in controlling body mass. When activated, it generally reduces food intake and promotes a state of greater energy use. Genetic or functional disturbances in this pathway have been associated with severe forms of obesity in both humans and experimental animals.
OPA1 is a protein found within mitochondria, the structures often described as the energy-producing units of cells. More specifically, OPA1 helps mitochondria maintain their internal architecture by promoting the fusion of mitochondrial membranes. This structural organization is essential for efficient energy production, regulation of cellular stress, and communication between metabolic pathways. Neurons have particularly high energy demands because they must maintain electrical gradients and continuously transmit signals. If mitochondrial function is impaired in appetite-regulating neurons, the resulting metabolic disturbance could alter how the brain interprets nutritional signals and controls feeding behavior.
To investigate that possibility, the researchers compared normal mice with genetically modified animals lacking OPA1 specifically in MC4R-expressing neurons. This neuron-specific approach allowed the team to examine the protein’s role in appetite regulation without eliminating OPA1 throughout the body, where it performs essential functions in many tissues. The animals were allowed to feed freely, and soybean oil was used as a dietary fat source. Rather than testing only a rigid, pre-measured diet, the free-feeding design enabled the researchers to observe how the mice voluntarily responded when fat was available as part of their food environment.
The results revealed a notable difference between male and female mice. In male wild-type animals, soybean oil increased the expression of OPA1, suggesting that dietary fat may trigger a mitochondrial adaptation in MC4R neurons. That response was not observed in females. The sex-specific pattern indicates that the neurons may process the metabolic consequences of dietary fat differently depending on biological sex. The researchers did not present the finding as evidence that OPA1 alone determines obesity, but it points to the protein as one component of a broader network connecting food composition, mitochondrial activity, neural signaling, and long-term body-weight regulation.
The consequences of removing OPA1 were especially striking over time. Mice without OPA1 in their MC4R neurons consumed more food and developed age-related weight gain, with obesity becoming more apparent as the animals grew older. When given access to both standard chow and soybean oil, the modified mice consumed more fat and gained additional weight. The effect was particularly pronounced in females, even though female wild-type mice did not show the same soybean-oil-associated increase in OPA1 expression seen in males. This apparent mismatch suggests that the absence of OPA1 may expose a vulnerability in female appetite-control circuits rather than simply preventing a protective response that occurs in males.
At the cellular level, the findings are consistent with the idea that mitochondria do more than supply energy. They also act as sensors and regulators of cellular conditions. Changes in mitochondrial fusion can influence the production of energy, reactive oxygen species, calcium handling, and the ability of neurons to respond to hormonal and nutrient-related signals. In MC4R neurons, such changes could affect the strength or timing of melanocortin signaling, potentially making the brain less effective at limiting food intake after energy needs have been met. The current study does not establish every step in that chain, but it provides experimental evidence that mitochondrial integrity within a defined neuronal population is linked to dietary-fat consumption and body-weight control.
The researchers also tested setmelanotide, a drug that activates MC4R and is used to treat certain forms of genetic obesity. In control male mice, the compound successfully suppressed appetite. It also reduced food intake in male mice lacking OPA1. In females, however, the appetite-suppressing effect was significantly weaker when OPA1 was absent from MC4R neurons. This result is important because it suggests that the effectiveness of an MC4R-targeting treatment may depend not only on whether the receptor is present, but also on the metabolic condition of the neurons that contain it. A receptor-activating drug may be less effective if the cellular machinery needed to translate that signal into sustained appetite control has been disrupted.
The study was conducted in mice, so its findings cannot yet be assumed to apply directly to people. Human appetite regulation involves numerous interacting systems, including hormones released by the gut and adipose tissue, reward pathways involved in food preference, sleep, stress, physical activity, and environmental access to calorie-dense foods. Soybean oil was also used as an experimental fat source and should not be interpreted as the sole cause of obesity in humans. Nevertheless, the work adds to growing evidence that dietary fat can influence the brain through mechanisms that extend beyond calorie intake alone. By identifying a link between OPA1, MC4R neurons, and sex-dependent responses to fat, the researchers provide a potential molecular target for future studies of personalized obesity therapies.
“Our findings provide key insights into the mechanisms underlying obesity from the perspective of neuronal energy metabolism,” Matsumura said. He added that the observed differences in OPA1 responses and obesity susceptibility could help guide treatments that account for sex-specific biology. Future research will need to determine how OPA1 is regulated in human appetite circuits, whether similar changes occur in people with obesity, and how mitochondrial dynamics interact with hormones and other signals that activate MC4R. The findings, published in The FASEB Journal, suggest that the battle against overeating may depend partly on the condition of microscopic energy systems inside the brain’s appetite-control neurons.
Subject of Research: Animals
Article Title: OPA1 in MC4R Neurons Regulates Dietary Fat Intake and Body Weight in Mice
News Publication Date: 21-May-2026
Web References: Osaka Metropolitan University, https://www.omu.ac.jp/en/
References: DOI: 10.1096/fj.202600452R
Image Credits: Osaka Metropolitan University
Keywords
OPA1, MC4R neurons, obesity, dietary fat, soybean oil, appetite regulation, mitochondria, hypothalamus, setmelanotide, body weight, sex differences, mice
Tags: age-related weight gain mechanismsanti-obesity drugs and neural responsebrain protein defectenergy expenditure regulation in the brainhypothalamic neurons and fat intakeMC4R receptor and dietary fat responsemitochondrial proteins and obesityneural circuits controlling hungerobesity and brain signaling pathwaysobesity research beyond digestive systemOPA1 protein and appetite regulationsex differences in obesity treatment
